A phase 2, double-blind, randomized, multicenter trial to evaluate the safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (pcv15) compared to pcv13 in healthy infants
ESPID Education. Platt H. 05/08/19; 263085
Heather Platt
Heather Platt
Only ESPID Members have access to the ESPID 2019 content. To become a member click here
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies